Dasatinib Impurity 63

Synchemia is a leading supplier in pharmaceutical Dasatinib Impurities . Dasatinib (marketed as Sprycel) is a kinase inhibitor primarily used to treat Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults and children. It treats newly diagnosed cases and patients resistant or intolerant to prior therapy, including imatinib.

Dasatinib Impurity 63 CAS NO: NA chemically represented as Ethyl (5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)carbamate . Dasatinib Impurity 63 is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Dasatinib Impurity 63 . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.